Press release
Related Press
22 February 2024
CSEM and ClexBio create a bioreactor for tissue-engineered cardiovascular implants
The teams at CSEM and at ClexBio have developed a process for engineering vein grafts comprised of human tissue material that integrates into the patient’s body and can turn into real, living tissue....
3 February 2023
Making personalized cancer therapies accessible to all
CSEM has supported Lausanne-based start-up Limula in its mission to make cell therapies more affordable, and to facilitate access to these personalized treatments. ...
11 January 2021
Biospectal Announces Public Beta Launch Of OptiBP™
Biospectal’s OptiBP smartphone app and data platform empowers people worldwide with a medical-grade device integrated directly into their smartphone, enabling instantaneous blood pressure measurement ...